53 results on '"Pallansch, Mark A."'
Search Results
2. Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial
3. Assessing country compliance with circulating vaccine-derived poliovirus type 2 outbreak response standard operating procedures: April 2016 to December 2020
4. Outbreak response strategies with type 2-containing oral poliovirus vaccines
5. Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawal
6. Assessing the immunogenicity of three different inactivated polio vaccine schedules for use after oral polio vaccine cessation, an open label, phase IV, randomized controlled trial
7. Serotype 2 oral poliovirus vaccine (OPV2) choices and the consequences of delaying outbreak response
8. The impact of disruptions caused by the COVID-19 pandemic on global polio eradication
9. Certifying the interruption of wild poliovirus transmission in the WHO African region on the turbulent journey to a polio-free world
10. Neutralization capacity of highly divergent type 2 vaccine-derived polioviruses from immunodeficient patients
11. Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial
12. Immunogenicity of type 2 monovalent oral and inactivated poliovirus vaccines for type 2 poliovirus outbreak response: an open-label, randomised controlled trial
13. Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule
14. Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigation
15. Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial
16. Effect of time at temperature on wild poliovirus titers in stool specimens
17. Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trial
18. Expansion of syndromic vaccine preventable disease surveillance to include bacterial meningitis and Japanese encephalitis: Evaluation of adapting polio and measles laboratory networks in Bangladesh, China and India, 2007–2008
19. First Confirmed Cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in the United States, Updated Information on the Epidemiology of MERS-CoV Infection, and Guidance for the Public, Clinicians, and Public Health Authorities—May 2014
20. Survey of poliovirus antibodies in Kano, Northern Nigeria
21. Oral polio vaccine response in breast fed infants with malnutrition and diarrhea
22. Population immunity to polioviruses in the context of a large-scale wild poliovirus type 1 outbreak in Tajikistan, 2010
23. Poliovirus vaccination options for achieving eradication and securing the endgame
24. Enterovirus 71 encephalitis: a new vaccine on the horizon?
25. Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6–9 months in Moradabad, India: a community-based, randomised controlled trial
26. Monovalent type 1 oral poliovirus vaccine among infants in India: Report of two randomized double-blind controlled clinical trials
27. Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsions
28. Economic analysis of the global polio eradication initiative
29. Parechovirus typing in clinical specimens by nested or semi-nested PCR coupled with sequencing
30. Optimal vaccine stockpile design for an eradicated disease: Application to polio
31. Histopathologic, immunohistochemical, and polymerase chain reaction assays in the study of cases with fatal sporadic myocarditis
32. Molecular identification of 13 new enterovirus types, EV79–88, EV97, and EV100–101, members of the species Human Enterovirus B
33. Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child
34. Survey of poliovirus antibodies during the final stage of polio eradication in Egypt
35. Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand
36. Environmental surveillance of wild poliovirus circulation in Egypt—Balancing between detection sensitivity and workload
37. Genomic evidence that simian virus 2 and six other simian picornaviruses represent a new genus in Picornaviridae
38. Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing
39. Molecular epidemiology and type-specific detection of echovirus 11 isolates from the Americas, Europe, Africa, Australia, southern Asia and the Middle East
40. Erratum to “Serotype-specific identification of enterovirus 71 by PCR”
41. Serotype-specific identification of enterovirus 71 by PCR
42. Molecular phylogeny of all human enterovirus serotypes based on comparison of sequences at the 5′ end of the region encoding VP2
43. Complete sequence of echovirus 23 and its relationship to echovirus 22 and other human enteroviruses
44. Erratum to “coxsackievirus B3 clinical isolates and murine myocarditis” [Virus research 41 (1996) 94]
45. Coxsackievirus B3 clinical isolates and murine myocarditis
46. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus
47. Genotypic variation in Coxsackievirus B5 isolates from three different outbreaks in the United States
48. Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala
49. Immunoglobulin class and subclass-specific monoclonal antibody sandwich ELISA for the detection of antibodies against coxsackieviruses B, types 1–5
50. Detection and identification of vaccine-related polioviruses by the polymerase chain reaction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.